Owens Robert C
Department of Clinical Pharmacy Services and Division of Infectious Diseases, Maine Medical Center, 22 Bramhall Street, Portland, ME 04102, USA.
Infect Dis Clin North Am. 2009 Sep;23(3):683-702. doi: 10.1016/j.idc.2009.04.015.
Critical-care units can be barometers for appropriate antimicrobial use. There, life and death hang on empirical antimicrobial therapy for treatment of infectious diseases. With increasing therapeutic empiricism, triple-drug, broad-spectrum regimens are often necessary, but cannot be continued without fear of the double-edged sword: a life-saving intervention or loss of life following Clostridium difficile infection, infection from a resistant organism, nephrotoxicity, cardiac toxicity, and so on. While broadened initial empirical therapy is considered a standard, it must be necessary, dosed according to pharmacokinetic-pharmacodynamic principles, and stopped when no longer needed. Antimicrobial stewardship interventions shepherd these considerations in antimicrobial therapy. With pharmacists and physicians trained in infectious disease and critical care, clear-cut interventions can be focused on beginning or growing a stewardship program, or proposing future studies.
重症监护病房可以作为合理使用抗菌药物的晴雨表。在那里,传染病的治疗依赖于经验性抗菌治疗来决定生死。随着治疗经验主义的增加,三联药物、广谱治疗方案往往是必要的,但如果不担心双刃剑效应就不能持续使用:这是一种挽救生命的干预措施,却可能因艰难梭菌感染、耐药菌感染、肾毒性、心脏毒性等导致患者死亡。虽然扩大初始经验性治疗被视为一种标准,但必须是必要的,要根据药代动力学-药效学原则给药,并且在不再需要时停药。抗菌药物管理干预措施将这些抗菌治疗的考虑因素贯穿其中。有了在传染病和重症监护方面接受过培训的药剂师和医生,明确的干预措施可以集中在启动或扩大管理计划,或提出未来的研究。